Malcom Sim
Malcolm is based in the Oxford Centre for Immuno-Oncology and his research focuses on receptors of the immune system that detect MHC molecules with a focus on natural killer cell receptors. Malcolm was awarded his PhD in 2016 from Imperial College London and conducted his post-doctoral training at the National Institute of Allergy and Infectious Diseases (NIAID) in the USA. He joined the University of Oxford in 2022 to set up his own research group and is funded by the Medical Research Council.

